Mercadolibre Inc vs 10X Genomics Inc — how do they compare? Mercadolibre Inc trades at $1,930.99 (market cap $98.35B), while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: Mercadolibre Inc is far larger — about 12.9× 10X Genomics Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, 10X Genomics Inc nearer its low. Which is the better fit depends on your goals.
| MELI | TXG | |
|---|---|---|
Market Cap | $98.35B | $7.61B |
Sector | Consumer Cyclical | Health |
52-Week High | $2.51K | $58.57 |
52-Week Low | $1.55K | $11.34 |
Enterprise Value | $106.00B | $7.14B |
Trailing returns across standard periods
Latest headlines on both assets
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →